Get Live Data

The next focusIR Investor Webinar takes places on 14th May with guest speakers from Blue Whale Growth Fund, Taseko Mines, Kavango Resources and CQS Natural Resources fund. Please register here.

Less Ads, More Data, More Tools Register for FREE
Roundtable Discussion; The Future of Mineral Sands
Roundtable Discussion; The Future of Mineral SandsView Video

Latest Share Chat

  2. Share Prices
  3. Glaxosmithkline Share Price
  4. Glaxosmithkline Share News
  5. BROKER RATINGS SUMMARY: Citi Cuts AB Foods As UBS Raises Smiths Group

Pin to quick picksGlaxosmithkline Share News (GSK)

Glaxosmithkline Information

Share Price Information for Glaxosmithkline (GSK)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 1,733.50
Bid: 1,732.50
Ask: 1,733.00
Change: 0.00 (0.00%)
Spread: 0.50 (0.029%)
Open: 0.00
High: 0.00
Low: 0.00
Prev. Close: 1,733.50
GSK Live PriceLast checked at -

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

BROKER RATINGS SUMMARY: Citi Cuts AB Foods As UBS Raises Smiths Group

Tue, 13th Oct 2015 08:43

LONDON (Alliance News) - The following shares received analyst recommendations Tuesday morning and Monday:
----------
FTSE 100
----------
CITIGROUP CUTS AB FOODS TO 'NEUTRAL' ('BUY')
----------
UBS RAISES SMITHS GROUP TO 'NEUTRAL' ('SELL') - TARGET 1,050 (1,000) PENCE
----------
EXANE BNP RAISES LAND SECURITIES PRICE TARGET TO 1,570 (1,500)P - 'OUTPERFORM'
----------
EXANE BNP RAISES BRITISH LAND PRICE TARGET TO 990 (960) PENCE - 'OUTPERFORM'
----------
JEFFERIES RAISES LLOYDS PRICE TARGET TO 104 (97) PENCE - 'BUY'
----------
JPMORGAN RAISES GLAXOSMITHKLINE TO 'NEUTRAL' ('UNDERWEIGHT'); RAISES PRICE TARGET TO 1370 (1320) PENCE
----------
FTSE 250
----------
MORGAN STANLEY CUTS WEIR GROUP TARGET TO 1200 (1360) PENCE - 'UNDERWEIGHT'
----------
UBS CUTS WEIR GROUP PRICE TARGET TO 1,800 (2,000) PENCE - 'BUY'
----------
LIBERUM RAISES BBA AVIATION TO 'HOLD' ('SELL') - TARGET 200 (182) PENCE
----------
LIBERUM INITIATES SOPHOS WITH 'BUY' - TARGET 290 PENCE
----------
UBS CUTS SPECTRIS PRICE TARGET TO 1,650 (1,820) PENCE - 'SELL'
----------
UBS CUTS MORGAN ADVANCED MATERIALS PRICE TARGET TO 280 (315) PENCE - 'SELL'
----------
UBS CUTS VESUVIUS PRICE TARGET TO 425 (520) PENCE - 'BUY'
----------
UBS CUTS IMI TO 'NEUTRAL' ('BUY') - TARGET 1,150 (1,400) PENCE
----------
EXANE BNP RAISES GREAT PORTLAND PRICE TARGET TO 950 (910) PENCE - 'OUTPERFORM'
----------
EXANE BNP RAISES DERWENT LONDON PRICE TARGET TO 4,000 (3,820) PENCE - 'NEUTRAL'
----------
JEFFERIES RAISES JUPITER FUND PRICE TARGET TO 493 (474) PENCE - 'BUY'
----------
CITIGROUP RAISES LADBROKES TO 'NEUTRAL' ('SELL') - TARGET 110 (100) PENCE
----------
UBS CUTS BODYCOTE PRICE TARGET TO 690 (750) PENCE - 'BUY'
----------
MAIN MARKET AND AIM
----------
NUMIS RAISES RWS HOLDINGS TO 'ADD' ('HOLD') - TARGET 158 (145) PENCE
----------
NUMIS RAISES SCAPA GROUP TO 'ADD' ('HOLD') - TARGET 211 PENCE
----------
LIBERUM CUTS NANOCO PRICE TARGET TO 105 (260) PENCE - 'BUY'
----------
PANMURE CUTS DIAMONDCORP PRICE TARGET TO 16.5 (23) PENCE - 'BUY'
----------
HSBC CUTS LONMIN PRICE TARGET TO 30 (82) PENCE - 'HOLD'
----------
UBS CUTS FENNER TO 'SELL' ('NEUTRAL') - TARGET 160 (175) PENCE
----------
TRADERS: INVESTEC INITIATES CENTAUR MEDIA WITH 'BUY' - TARGET 92 PENCE
----------
TRADERS: UBS CUTS FENNER TO 'SELL' ('NEUTRAL')
----------
TRADERS: STIFEL INITIATES ALLERGY THERAPEUTICS WITH 'BUY' - TARGET 79 PENCE
----------
Berenberg Ups DFS Furniture Price Target To 360p From 350p, Keeps Buy
----------
By Arvind Bhunjun; arvindbhunjun@alliancenews.com; @ArvindBhunjun

Copyright 2015 Alliance News Limited. All Rights Reserved.

More News
17 Dec 2023 15:16

PRESS: GSK looks for deals in China as rebuilds relationship

(Alliance News) - The Financial Times on Sunday reported that GSK PLC is looking for some new deals in China.

Read more
15 Dec 2023 17:08

European shares end fifth week higher on rate-cut optimism

Barclays sees first ECB rate cut in April

*

Read more
15 Dec 2023 16:51

LONDON MARKET CLOSE: FTSE 100 underperforms as post-Fed rally cools

(Alliance News) - London's FTSE 100 ended lower on Friday, with profit-taking and some hawkish words from a US policymaker keeping equities in check at the end of a largely positive week for stocks.

Read more
15 Dec 2023 16:29

PRESS: GSK, Astra and AbbVie in US scrutiny over patents - Bloomberg

(Alliance News) - A US senator has accused AstraZeneca PLC, GSK PLC, AbbVie Inc and other drugmakers of "abusing" the patent system to send prices higher, Bloomberg reported on Thursday.

Read more
12 Dec 2023 10:08

AstraZeneca buys respiratory vaccine developer Icosavax in $1.1 bln deal

Dec 12 (Reuters) - AstraZeneca said on Tuesday it had agreed to buy respiratory syncytial virus (RSV) vaccine developer Icosavax in a deal valued at up to $1.1 billion.

Read more
12 Dec 2023 08:22

TOP NEWS: Japan accepts GSK's filing for respiratory disease vaccine

(Alliance News) - GSK PLC on Tuesday said Japan's Ministry of Health, Labour & Welfare has accepted its regulatory application for the extension of its respiratory syncytial virus vaccine, Arexvy, for adults aged 50-59.

Read more
12 Dec 2023 07:39

LONDON BRIEFING: UK unemployment unchanged at 4.2%; eyes on US CPI

(Alliance News) - Stocks in London are called to open higher, as investors digest the latest UK unemployment data, before turning their heads to US inflation.

Read more
12 Dec 2023 07:24

GSK seeks to extend RSV vaccine approval in Japan

(Sharecast News) - GSK announced on Tuesday that Japan's Ministry of Health, Labour and Welfare (MHLW) has accepted its regulatory application for the extension of the indication of its RSV vaccine to include adults aged 50- to 59 at an increased risk of contracting the disease.

Read more
11 Dec 2023 08:28

GSK drug gets EU marketing backing for form of endometrial cancer

(Alliance News) - GSK PLC on Monday said it won EU backing for its Jemperli drug in tandem with chemotherapy to treat a form of endometrial cancer.

Read more
11 Dec 2023 07:41

LONDON BRIEFING: GSK drug gets EU endorsement; Begbies backs outlook

(Alliance News) - London's FTSE 100 is called to open a touch lower on Monday, kicking off the week with some slight trepidation after Friday's hotter-than-expected US jobs report which offered the dollar some respite.

Read more
11 Dec 2023 07:23

GSK endometrial cancer treatment gets Europe authorisation

(Sharecast News) - GSK announced on Monday that the European Commission has granted marketing authorisation for 'Jemperli', or dostarlimab, in combination with chemotherapy for certain endometrial cancers.

Read more
7 Dec 2023 12:54

THG backer Kelso pushes for demerger to trim "inherent" valuation gap

(Alliance News) - THG PLC investor Kelso Group Holdings PLC on Thursday reiterated its call for a demerger, which the shareholder believes will help close the "disparity" between the e-commerce firm's share price and its true value.

Read more
5 Dec 2023 10:02

LONDON BROKER RATINGS: Goldman lifts Landsec and British Land

(Alliance News) - The following London-listed shares received analyst recommendations Tuesday morning and Monday:

Read more
27 Nov 2023 09:00

GSK announces positive results from Blenrep phase 3 blood cancer trial

(Alliance News) - GSK PLC on Monday said a phase 3 trial of belantamab mafodotin as a multiple myeloma treatment has produced positive headline results.

Read more
27 Nov 2023 08:02

GSK receives 'positive' headline results from phase III trial

(Sharecast News) - Drugmaker GSK announced on Monday that it had received positive headline results from a planned interim efficacy analysis from a phase III trial evaluating its elantamab mafodotin asset.

Read more
5678910111213

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.